These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 28620200)
1. Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats. Li CY; Song HT; Wang XX; Wan YY; Ding XS; Liu SJ; Dai GL; Liu YH; Ju WZ Sci Rep; 2017 Jun; 7(1):3619. PubMed ID: 28620200 [TBL] [Abstract][Full Text] [Related]
2. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study. Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504 [TBL] [Abstract][Full Text] [Related]
3. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats. Ji H; Liu Y; He F; An R; Du Z J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861 [TBL] [Abstract][Full Text] [Related]
4. Investigating the inter-individual variability of Astragali Radix against cisplatin-induced liver injury via 16S rRNA gene sequencing and LC/MS-based metabolomics. Wang L; Dong XL; Qin XM; Li ZY Phytomedicine; 2022 Jul; 101():154107. PubMed ID: 35561503 [TBL] [Abstract][Full Text] [Related]
5. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats. Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187 [TBL] [Abstract][Full Text] [Related]
6. Urinary metabonomics elucidate the therapeutic mechanism of Orthosiphon stamineus in mouse crystal-induced kidney injury. Gao S; Chen W; Peng Z; Li N; Su L; Lv D; Li L; Lin Q; Dong X; Guo Z; Lou Z J Ethnopharmacol; 2015 May; 166():323-32. PubMed ID: 25794803 [TBL] [Abstract][Full Text] [Related]
7. Urinary metabolomics research for Huangqi Jianzhong Tang against chronic atrophic gastritis rats based on Liu Y; Jin Z; Qin X; Zheng Q J Pharm Pharmacol; 2020 May; 72(5):748-760. PubMed ID: 32128823 [TBL] [Abstract][Full Text] [Related]
9. Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats. Zhang P; Chen JQ; Huang WQ; Li W; Huang Y; Zhang ZJ; Xu FG Sci Rep; 2017 Mar; 7():44804. PubMed ID: 28300186 [TBL] [Abstract][Full Text] [Related]
10. Urinary metabolomics study the mechanism of Taohong Siwu Decoction intervention in acute blood stasis model rats based on liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. Zhang X; Li P; Hua Y; Ji P; Yao W; Ma Q; Yuan Z; Wen Y; Yang C; Wei Y J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():51-60. PubMed ID: 29331744 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Saad SY; Najjar TA; Daba MH; Al-Rikabi AC Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106 [TBL] [Abstract][Full Text] [Related]
12. Metabolic Profile Changes of CCl₄-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule. Wang G; Li Z; Li H; Li L; Li J; Yu C Molecules; 2016 May; 21(6):. PubMed ID: 27248993 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention. Zhang A; Liu Q; Zhao H; Zhou X; Sun H; Nan Y; Zou S; Ma CW; Wang X Sci Rep; 2016 Jan; 6():19333. PubMed ID: 26785698 [TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of copper-laden hepatolenticular degeneration model rats and the interventional effects of Gandou decoction using UPLC-Q-TOF/MS. Cheng M; Wu H; Wu H; Liu X; Zhou A J Pharm Biomed Anal; 2019 Feb; 164():187-195. PubMed ID: 30390561 [TBL] [Abstract][Full Text] [Related]
15. A non-target urinary and serum metabolomics strategy reveals therapeutical mechanism of Radix Astragali on adjuvant-induced arthritis rats. Xu T; Feng G; Zhao B; Zhao J; Pi Z; Liu S; Song F; Liu Z J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():94-101. PubMed ID: 28232289 [TBL] [Abstract][Full Text] [Related]
16. LC-MS-based metabolomics reveals metabolic changes in short- and long-term administration of Compound Danshen Dripping Pills against acute myocardial infarction in rats. Zhang L; Wang LL; Zeng H; Li B; Yang H; Wang GJ; Li P Phytomedicine; 2022 Sep; 104():154269. PubMed ID: 35717805 [TBL] [Abstract][Full Text] [Related]
17. Integrated Systems Pharmacology, Urinary Metabonomics, and Quantitative Real-Time PCR Analysis to Uncover Targets and Metabolic Pathways of the You-Gui Pill in Treating Kidney-Yang Deficiency Syndrome. Chen R; Wang J; Zhan R; Zhang L; Wang X Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357410 [TBL] [Abstract][Full Text] [Related]
18. Methylglyoxal and D-lactate in cisplatin-induced acute kidney injury: Investigation of the potential mechanism via fluorogenic derivatization liquid chromatography-tandem mass spectrometry (FD-LC-MS/MS) proteomic analysis. Chen SM; Chen TH; Chang HT; Lin TY; Lin CY; Tsai PY; Imai K; Chen CM; Lee JA PLoS One; 2020; 15(7):e0235849. PubMed ID: 32649695 [TBL] [Abstract][Full Text] [Related]
19. Non-target metabonomic method provided new insights on the therapeutical mechanism of Gancao Fuzi decoction on rheumatoid arthritis rats. Liu Y; Wei M; Yue K; Wang R; Ma Y; Men L; Pi Z; Liu Z; Liu Z J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():93-103. PubMed ID: 30576890 [TBL] [Abstract][Full Text] [Related]
20. Characterization of urinary metabolites as biomarkers of colistin-induced nephrotoxicity in rats by a liquid chromatography/mass spectrometry-based metabolomics approach. Jeong ES; Kim G; Moon KS; Kim YB; Oh JH; Kim HS; Jeong J; Shin JG; Kim DH Toxicol Lett; 2016 Apr; 248():52-60. PubMed ID: 26947560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]